Reference
Joshi TP, et al. Treatment with Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma. JAMA Dermatology 158: 697-699, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1001/jamadermatol.2022.0613
Rights and permissions
About this article
Cite this article
Antimalarials/doxycycline/steroids. Reactions Weekly 1940, 48 (2023). https://doi.org/10.1007/s40278-023-31906-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-31906-5